EP3645518
Efnasmíði á ómekamtív-mekarbíl
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
29.6.2018EP published:
19.5.2021EP application number:
18743314.9
EP translation filed:
11.8.2021Grant published:
15.9.2021EPO information:
European Patent Register
Max expiry date:
28.6.2038Expiry date:
28.6.2026Next due date:
30.6.2026
Title:
SYNTHESIS OF OMECAMTIV MECARBIL
Timeline
Today
29.6.2018EP application
19.5.2021EP Publication
11.8.2021Translation submitted
15.9.2021Registration published
28.6.2026Expires
Owner
Name:
Amgen Inc.Address:
One Amgen Center Drive, Thousand Oaks, California 91320-1799, US
Inventor
Name:
CAILLE, SebastienAddress:
Moorpark CA 93021, US
Name:
QUASDORF, KyleAddress:
Thousand Oaks CA 91360, US
Name:
ROOSEN, PhilippAddress:
Thousand Oaks CA 91320, US
Name:
SHI, XianqingAddress:
Newbury Park CA 91320, US
Name:
COSBIE, AndrewAddress:
Ventura CA 93003, US
Name:
WANG, FangAddress:
Simi Valley CA 93065, US
Name:
WU, ZufanAddress:
Walnut CA 91789, US
Name:
NEERGUNDA, ArchanaAddress:
Simi Valley CA 93063, US
Name:
QUAN, Bin, PeterAddress:
Woodland CA 91364, US
Name:
GUAN, LianxiuAddress:
Camarillo CA 93010, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201762527174 PDate:
30.6.2017Country:
US
Number:
201862664363 PDate:
30.4.2018Country:
US
Classification
Categories:
C07D 295/205, C07D 213/75
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 11.8.2021
Expires: 28.6.2022
Payer: Árnason Faktor ehf.
Number: 5
Paid: 6.5.2022
Expires: 28.6.2023
Payer: Árnason Faktor ehf.
Number: 6
Paid: 24.5.2023
Expires: 28.6.2024
Payer: Árnason Faktor ehf.
Number: 7
Paid: 7.5.2024
Expires: 28.6.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 10.6.2025
Expires: 28.6.2026
Payer: Árnason Faktor ehf.